Cargando…
Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm
BACKGROUND: Multiple observational studies have associated metformin prescription with reduced progression of abdominal aortic aneurysm (AAA). The Metformin Aneurysm Trial (MAT) will test whether metformin reduces the risk of AAA rupture-related mortality or requirement for AAA surgery (AAA events)...
Autores principales: | Golledge, Jonathan, Arnott, Clare, Moxon, Joseph, Monaghan, Helen, Norman, Richard, Morris, Dylan, Li, Qiang, Jones, Greg, Roake, Justin, Bown, Matt, Neal, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710921/ https://www.ncbi.nlm.nih.gov/pubmed/34961561 http://dx.doi.org/10.1186/s13063-021-05915-0 |
Ejemplares similares
-
Association Between Metformin and Abdominal Aortic Aneurysm: A Meta-Analysis
por: Niu, Wenqiang, et al.
Publicado: (2022) -
Metformin ameliorates established abdominal aortic aneurysms induced by elastase in mice
por: Lu, Hong S., et al.
Publicado: (2023) -
Inhibition of angiotensin-induced aortic aneurysm by metformin in apolipoprotein E–deficient mice
por: Kunath, Anne, et al.
Publicado: (2021) -
Mechanisms and efficacy of metformin-mediated suppression of established experimental abdominal aortic aneurysms
por: Xu, Baohui, et al.
Publicado: (2023) -
Randomized Placebo‐Controlled Trial Assessing the Effect of 24‐Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME‐2 Trial
por: Pinchbeck, Jenna L., et al.
Publicado: (2018)